In addition to effectively lowering blood sugar and assisting with weight loss, semaglutide has been shown to reduce the risk of cardiovascular disease in people with and without Type 2 diabetes
10.1001/archsurg.1951.01250040701017 93 CryanJ
Great to see this Jim
A 2026 UK review of the ONSs 9,809 UK alcohol-specific deaths in 2024 , the 2025 no safe level brain-volume and dementia data, how chronic drinking suppresses hippocampal BDNF and adult neurogenesis (with the 2026 Frontiers in Psychiatry proBDNF study), the thiamine/WernickeKorsakoff emergency you must not miss, how cognition and hippocampal volume recover in abstinence, the 2025 semaglutide alcohol-use-disorder trial and why cutting down, thiamine and a medically supervised detox come first, not a peptide Read the full review Pharmacology & Drug-Induced Neuroscience 10 June 2026 Dihexa for Statin Brain Fog: Statins, Memory, Brain Cholesterol & the 2026 UK Review Do statins cause brain fog and can a synaptogenic peptide help, or just distract from reviewing the statin
A quick recap of how we got to this point: 2022: Surging GLP-1 demand outpaced
Resting metabolic rate continues its gradual decline, meaning the body burns fewer calories at rest than it did in earlier decades